KYMR Return on Tangible Equity | KYMERA THERAPEUTICS, INC.

KYMERA THERAPEUTICS, INC. (KYMR) Return on Tangible Equity

2026-06-30: Return Tang Equity -19.85%.
2026-03-31: Return Tang Equity -20.46%.
2025-12-31: Return Tang Equity -19.71%.
2025-09-30: Return Tang Equity -31.19%.

Complete source-backed return tang equity history.

Available history: 2019-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-19.85%
2026-03-31	-20.46%
2025-12-31	-19.71%
2025-09-30	-31.19%
2025-06-30	-28.35%
2025-03-31	-30.64%
2024-12-31	-26.79%
2024-09-30	-18.76%
2024-06-30	-23.05%
2024-03-31	-21.74%
2023-12-31	-37.21%
2023-09-30	-42.34%
2023-06-30	-36.19%
2023-03-31	-34.43%
2022-12-31	-31.58%
2022-09-30	-30.00%
2022-06-30	-35.04%
2022-03-31	-28.88%
2021-12-31	-21.80%
2021-09-30	-16.35%
2021-06-30	-22.63%
2021-03-31	-17.34%
2020-12-31	-16.06%
2020-09-30	-15.07%
2020-06-30	44.60%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-19.71%
2024-12-31	-26.79%
2023-12-31	-37.21%
2022-12-31	-31.58%
2021-12-31	-21.80%
2020-12-31	-16.06%
2019-12-31	55.43%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
CG Oncology, Inc. (CGON)	United States	$6.095B	-27.95
Scholar Rock Holding Corp (SRRK)	United States	$5.920B	-16.37